http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2369315-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04 |
| filingDate | 2008-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0eeeb4f53dc69429850cabe203d72a2a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c04ac706848a17409aca7d195a978cee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1f8a369915641529fb573156f80434c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c7bf89a5bbfaddf318eccb027b27399 |
| publicationDate | 2011-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2369315-T3 |
| titleOfInvention | PIPERIDINE-AMIDE DERIVATIVES. |
| abstract | Compounds of the formula (I) 1 NOR OX 2 RY (I) in which X is S eYesCR3, or X is CR3eYesS; R1 is aryl or heteroaryl, said aryl or heteroaryl can be optionally substituted by 1-3 substituents independently chosen from the group consisting of halogen, hydroxy, CN, lower alkyl and hydroxy-lower alkyl; R2 is aryl, heteroaryl or aryl-lower alkyl, said aryl or heteroaryl may optionally be substituted by 13 substituents independently chosen from the group consisting of lower alkyl, halogen, hydroxy, CN, NO2, fluoro-lower alkyl, lower alkoxy , fluoro-lower alkoxy, S (O2) R4, C (O) R5, imidazolyl, pyrazolyl, tetrazolyl, pyrrolyl and NR6R7, said lower alkyl or lower alkoxy is optionally substituted by hydroxy, COOH, carbamoyl, amino, halogen or lower alkoxy ; R3 is hydrogen, halogen, CN, lower alkyl, fluoro-lower alkyl, lower alkoxy, fluoro-lower alkoxy or lower alkoxy-lower alkyl; R4 is lower alkyl or amino; R5 is hydrogen, hydroxy, lower alkyl, lower alkoxy, or amino; R6 and R7 independently of one another are hydrogen, lower alkyl, lower alkyl-carbonyl or lower alkyl-SO2; and its pharmaceutically acceptable salts and esters; where the term " lower alkyl " it is a linear or branched chain monovalent alkyl radical of one to seven carbon atoms; and the term " lower alkoxy " is the group R'-O-, where R 'is a lower alkyl. |
| priorityDate | 2007-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 559.